PLAT and Stroke: However, only one randomized trial was included in the present meta-analysis. Given the possibility that efficacy is optimized using the standard of 0.9 mg/ kg tPA, a randomized dose-comparison study is an important research priority to establish the optimal tPA dose in stroke patients.